EGFR is also overexpressed in NSCLC [12], and activation of EGFR signaling (EGFR gene amplification and active mutations) is a critical driving force for NSCLC (~ 85%) [10]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.